CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity

European Journal of Dermatology

Volumn 18, Issue 1, 2008, Pages 41-49

  Oflazoglu, Ezogelin ^a   Simpson, Eric L ^b   Takiguchi, Rodd ^b   Grewal, Iqbal S ^a   Hanifin, Jon M ^b   Gerber, Hans Peter ^a  

^a SEATTLE GENETICS INC   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Atopic dermatitis; CD30; CD8 T cells; Chemokine; Langerhans cells

Indexed keywords

CD30 ANTIGEN; IMMUNOGLOBULIN E; T6 ANTIGEN;

ARTICLE; ATOPIC DERMATITIS; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; LANGERHANS CELL; MEMORY T LYMPHOCYTE; SKIN DEFECT;

ANTIGENS, CD1; ANTIGENS, CD30; ANTIGENS, CD4; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL17; CHEMOKINES, CC; DERMATITIS, ATOPIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LANGERHANS CELLS; SKIN;

EID: 38549151813     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0309     Document Type: Article

References (39)

1. Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin North Am 2006; 90: 149-67; (ix).
2. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-7.
3. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13-4.
4. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group Exp Dermatol 2001; 10: 11-8.
5. Hanifin JM, Tofte SJ. Update on therapy of atopic dermatitis. J Allergy Clin Immunol 1999; 104: S123-S125.
6. Kaudewitz P, Stein H, Burg G, Mason DY, Braun-Falco O. Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol 1986; 86: 350-4.
7. Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol 1999; 90: 157-64.
8. Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, Lunardi C. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol 2000; 164: 4399-407.
9. McMillan SA, McDonnell GV, Douglas JP, Hawkins SA. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis. Acta Neurol Scand 2000; 101: 239-43.
10. Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease. J Rheumatol 2000; 27: 698-702.
11. Bengtsson A, Holm L, Back O, Fransson J, Scheynius A. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol 1997; 109: 533-7.
12. Dummer W, Brocker EB, Bastian B. C. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Br J Dermatol 1997; 137: 185-7.
13. Caproni M, Bianchi B, D'Elios MM, De Carli M, Amedei A, Fabbri P. In vivo relevance of CD30 in atopic dermatitis. Allergy 1997; 52: 1063-70.
14. Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pita O. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997; 52: 106-9.
15. Cavagni G, Caffarelli C, Facchetti F, Brugnoni D, Notarangelo LD, Tosoni C, Altobelli R. Cutaneous CD30+ cells in children with atopic dermatitis. Int Arch Allergy Immunol 2000; 121: 224-8.
16. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM. Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today 1991; 12: 392-5.
17. Dummer W, Rose C, Brocker EB. Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis. Arch Dermatol Res 1998; 290: 598-602.
18. Yamamoto J, Adachi Y, Onoue Y, Kanegane H, Miyawaki T, Toyoda M, Seki T, Morohashi M. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 2000; 55: 1011-8.
19. Xerri L, Carbuccia N, Parc P, Hassoun J, Birg F. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology 1995; 27: 235-41.
20. Pivarcsi A, Gombert M, Dieu-Nosjean MC, Lauerma A, Kubitza R, Meller S, Rieker J, Muller A, Da Cunha L, Haahtela A, Sonkoly E, Fridman WH, Alenius H, Kemeny L, Ruzicka T, Zlotnik A, Homey B. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J Immunol 2004; 173: 5810-7.
21. Gunther C, Bello-Fernandez C, Kopp T, Kund J, Carballido-Perrig N, Hinteregger S, Fassl S, Schwarzler C, Lametschwandtner G, Stingl G, Biedermann T, Carballido JM. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 2005; 174: 1723-8.
22. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, Tamaki K. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002; 127: 270-3.
23. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chantry D, Suzuki R, Yoshie O. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002; 110: 139-46.
24. Lin L, Nonoyama S, Oshiba A, Kabasawa Y, Mizutani S. TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients. J Med Dent Sci 2003; 50: 27-33.
25. Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004; 34: 201-8.
26. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005; 60: 685-8.
27. Latza U, Davis S, Wilhelm D, McKnight B, Seyfarth M, Stein H. Soluble cytokine receptor CD30 in atopic disorders: a case-control study. Clin Exp Allergy 1999; 29: 97-104.
28. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
29. Akdis CA, Akdis M, Simon HU, Blaser K. Regulation of allergic inflammation by skin-homing T cells in allergic eczema. Int Arch Allergy Immunol 1999; 118: 140-4.
30. Miyahara N, Swanson BJ, Takeda K, Taube C, Miyahara S, Kodama T, Dakhama A, Ott VL, Gelfand EW. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med 2004; 10: 865-9.
31. Miyahara N, Takeda K, Kodama T, Joetham A, Taube C, Park JW, Miyahara S, Balhorn A, Dakhama A, Gelfand EW. Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J Immunol 2004; 172: 2549-58.
32. Wollenberg A, Bieber T. Two populations of CD1a+ epidermal dendritic cells expressing B7 molecules in human skin. Br J Dermatol 1998; 138: 358-9.
33. Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P. Langerhans cells - dendritic cells of the epidermis. APMIS 2003; 111: 725-40.
34. Morhenn VB. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide. Immunol Today 1997; 18: 433-6.
35. Cumberbatch M, Singh M, Dearman RJ, Young HS, Kimber I, Griffiths CE. Impaired Langerhans cell migration in psoriasis. J Exp Med 2006; 203: 953-60.
36. Uno H, Hanifin JM. Langerhans cells in acute and chronic epidermal lesions of atopic dermatitis, observed by L-dopa histofluorescence, glycol methacrylate thin secretion, and electron microscopy. J Invest Dermatol 1980; 75: 52-60.
37. Fischer M, Harvima IT, Carvalho RF, Moller C, Naukkarinen A, Enblad G, Nilsson G. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 2006; 116: 2748-56.
38. Hermes B, Worm M, Nowak F, Kroczek RA, Stein H, Henz BM. Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. Acta Derm Venereol 1997; 77: 441-5.
39. Howard LM, Kohm AP, Castaneda CL, Miller SD. Therapeutic blockade of TCR signal transduction and co-stimulation in autoimmune disease. Curr Drug Targets Inflamm Allergy 2005; 4: 205-16.